Disease burden and progression in patients with new-onset mild cognitive impairment and Alzheimer’s disease identified from Japanese claims data: Evidence from the LIFE Study.
Disease burden and progression in patients with new-onset mild cognitive impairment and Alzheimer’s disease identified from Japanese claims data: Evidence from the LIFE Study.